Severe cases of occupational hand eczema may predict unemployment or days missed from work

March 20, 2006

Hand eczema caused by soaps and other irritants in the workplace may lead to unemployment or prolonged sick leaves from work for some individuals, according to an article in the March issue of Archives of Dermatology, one of the JAMA/Archives journals.

Hand eczema or dermatitis is characterized by redness and inflammation of the hands, often due to irritants in soap, chemicals or detergents. "Occupational hand eczema (OHE) has become a disease of increasing importance during recent decades because of its serious consequences, such as frequent eruptions and risk of prolonged sick leave," background information in the article states. OHE also greatly affects quality of life (QOL). Past studies name OHE as the most frequently recognized occupational disease in Denmark and many Western countries.

Rikke Skoet Cvetkovski, M.D., Ph.D., of the University of Copenhagen, Hellerup, Denmark, and colleagues studied patients with OHE to identify predictive risk factors for the disease. Patients listed in the Danish National Board of Industrial Injuries Registry as having OHE between Oct. 1, 2001, and Nov. 10, 2002, received questionnaires regarding sick leave, loss of job, depression, health-related quality of life and their eczema's severity. A follow-up questionnaire was sent one year after the first was returned. Of the 621 patients who responded to the first questionnaire, 564 (386 women and 178 men) completed the follow-up.

During follow-up, 25 percent of surveyed patients had persistently severe or aggravated OHE, 41 percent improved and 34 percent of patients experienced unchanged minimal or mild to moderate OHE. The groups most affected by OHE were butchers, kitchen workers and cooks, hairdressers and patients aged 25 to 29 years. Having a severe case of OHE, being 40 years of age or older and having a low self-rated quality of life predicted unemployment and prolonged sick leave (more than five weeks in the past year). Also, patients with a lower socioeconomic status (based on education and job status) were at high risk for prolonged sick leave, a change of job and unemployment.

"Predictive factors could be used by clinicians to guide treatment and to select early risk management strategies," the authors write. "To avoid prolonged sick leave that may lead to social and economic decline, physicians must try to identify subgroups of patients who are at greater risk of a poor outcome."
-end-
(Arch Dermatol. 2006; 142: 305 - 311. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: This study was supported by the Danish National Board of Industrial Injuries, the Danish Council for Research Policy, and the Danish National Institute of Occupational Health, Copenhagen.

The JAMA Network Journals

Related Eczema Articles from Brightsurf:

Vitamin D lessens symptoms of severe eczema in children
Vitamin D supplementation eased the symptoms experienced by children with severe atopic dermatitis, or eczema, in a recent randomized controlled trial published in Pharmacology Research & Perspectives.

TV ads for psoriasis and eczema medications portray few people of color
Commercials from pharmaceutical companies advertising medication to treat psoriasis and eczema lack people from racial and ethnic minorities, according to research from the Perelman School of Medicine at the University of Pennsylvania.

NIH-supported scientists demonstrate how genetic variations cause eczema
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development of atopic dermatitis, commonly known as eczema.

Biomedical researchers get closer to why eczema happens
A new study from researchers at Binghamton University, State University of New York may help to peel back the layers of unhealthy skin -- at least metaphorically speaking -- and get closer to a cure.

Researchers uncover novel approach for treating eczema
Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder's debilitating effects.

Revving up immune system may help treat eczema
Studying eczema, researchers at Washington University School of Medicine in St.

Childhood eczema cannot be prevented by daily moisturiser use, study finds
Using moisturisers on newborn babies does not prevent eczema as previously thought, according to a major new study.

Atopic eczema linked to increase fracture risk in adults
Adults with atopic eczema could face a raised risk of fracture, with the risk increasing the more severe the condition, according to a new study published in the Journal of Allergy and Clinical Immunology.

Long-term dupilumab benefits adolescents with eczema
Results from a phase IIa open-label trial and a subsequent phase III open-label extension trial reinforce findings from an earlier short-term trial that adolescents with moderate-to-severe atopic dermatitis, or eczema, can experience significant improvements with dupilumab.

Multiple genes affect risk of asthma, hay fever and eczema
In a new study from SciLifeLab at Uppsala University, researchers have found a total of 141 regions (genes) in our genetic material that largely explain the genetic risk underlying asthma, hay fever and eczema.

Read More: Eczema News and Eczema Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.